Moreover, tumors with molecular apocrine phenotype, i.e., expressing both AR and FOXA1 biomarkers, exhibited significantly lower density of intra-tumor CD11b- or CXCR2-positive cells (p = 0.001 and p = 0.006, respectively). This evidence concerns the gene FOXA1 and neoplasm.